<DOC>
	<DOC>NCT00977249</DOC>
	<brief_summary>Primary aim: Will varenicline be better than placebo to get long-term users of NRT to stop? Secondary aim: To assess in details some side effects of varenicline i.e. nausea and abnormal dreams.</brief_summary>
	<brief_title>Varenicline for Long-term Nicotine Replacement Therapy (NRT) Users</brief_title>
	<detailed_description>100-200 long-term users of NRT will be enrolled in a placebo, controlled, randomized trial with varenicline or placebo for 12 weeks to stop the use of NRT. Assessments consist of carbon monoxide in expired air, p-cotinine, body-weight, questions about craving, nausea and dreams. Primary result is percent not using NRT and not smoking at 12 weeks (point prevalence last 7 days) and secondary result is not smoking and not using NRT at 12 months. Secondary aims, is a more detailed assessment of nausea and dreams; well-known side effects of varenicline and secondary results are a qualitative description of nausea and dreams.</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<criteria>Longterm, daily NRT users (except nicotine patch) (&gt;11 months) exsmokers that are willing to try to stop the use of NRT and adhere to this protocol. More than 4 pieces of nicotine gum/ sublingual tablets/ lozenges/ per day, OR more than 3 inhaler cylinders per day, OR more than 10 puffs of nasal spray per day. Age &lt; 18 years, CO Smokers, Pregnant and lactating women, Used varenicline before, Not able to cooperate, Other significant diseases that might influence the trial (such as moderate severe cardiac disease, lung cancer,) in expired air &gt; 7 ppm.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>long term nicotine gum use</keyword>
	<keyword>varenicline</keyword>
	<keyword>adverse effects</keyword>
</DOC>